← Scroll for more →
Indivior Pharmaceuticals, Inc. (INDV)
Pharmaceutical Preparations
Latest Price
$35.37
TTM P/E
9.85
Normalized P/E
21.78
TTM Div Yield
--
Fwd Div Yield
--
Book Value
--
P/B Ratio
--
Valuation metrics
adjust assumptions →Norm. op. income: $32M (median of 3yr)
Tax rate: 45%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$0.65
98% downside
EPS: $1.64
Target P/E: 22×
Formula: EPS × P/E
P/E Fair Value
$36.08
+2% upside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18.71M | $767.0M | 15.72% | +167.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.57M | $310.0M | 6.36% | -319.5K | 2026-06-30 |
| Oaktree Capital Management LP | 6.13M | $251.0M | 5.15% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 5.50M | $225.0M | 4.62% | -91.1K | 2026-06-30 |
| State Street Corp | 4.99M | $204.0M | 4.20% | +88.1K | 2026-06-30 |
| Fuller & Thaler Asset Management, Inc. | 4.62M | $189.0M | 3.88% | +86.2K | 2026-06-30 |
| Two Seas Capital LP | 3.48M | $142.0M | 2.92% | -1.27M | 2026-06-30 |
| Morgan Stanley | 3.40M | $139.0M | 2.85% | -110.1K | 2026-06-30 |
| Franklin Resources Inc | 3.32M | $136.0M | 2.79% | +3.20M | 2026-06-30 |
| Geode Capital Management, LLC | 3.16M | $129.0M | 2.66% | +234.2K | 2026-06-30 |